Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
EpiVax Therapeutics, Inc. See All Filings	D	2021-02-22 12:00:11 UTC
Amount To Be Raised $369,881 Associated Brokers / Dealers N/A CIK Number 0001724741 Filed Document 0001724741-21-000002 Exclusions or Exemptions 506b Accepted Date 2021-02-22 12:00:11 UTC Type of Offering D Industry Biotechnology Principal Place of Business RHODE ISLAND Revenue or Assets Decline to Disclose Type of Security Equity
EpiVax Therapeutics, Inc. See All Filings	D	2021-02-22 11:58:13 UTC
Amount To Be Raised $3,000,000 Associated Brokers / Dealers N/A CIK Number 0001724741 Filed Document 0001724741-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-02-22 11:58:13 UTC Type of Offering D Industry Biotechnology Principal Place of Business RHODE ISLAND Revenue or Assets Decline to Disclose Type of Security Equity
EpiVax Oncology, Inc. See All Filings	D	2019-10-07 15:37:18 UTC
Amount To Be Raised $1,250,000 Associated Brokers / Dealers N/A CIK Number 0001724741 Filed Document 0001724741-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-10-07 15:37:18 UTC Type of Offering D Industry Biotechnology Principal Place of Business NEW YORK Revenue or Assets Decline to Disclose Type of Security Debt
EpiVax Oncology, Inc. See All Filings	D/A	2018-12-14 10:03:49 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001724741 Filed Document 0001724741-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-12-14 10:03:49 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business RHODE ISLAND Revenue or Assets Decline to Disclose Type of Security Option To Acquire
EpiVax Oncology, Inc. See All Filings	D	2017-12-11 12:35:06 UTC
Amount To Be Raised $2,000,000 Associated Brokers / Dealers N/A CIK Number 0001724741 Filed Document 0001724741-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-12-11 12:35:06 UTC Type of Offering D Industry Biotechnology Principal Place of Business RHODE ISLAND Revenue or Assets Decline to Disclose Type of Security Option To Acquire